RNA-protein interactions could lead to new coronavirus drug targets

A study co-led by a University of California, Riverside, biomedical scientist has identified new targets for coronavirus antiviral drugs, including treatments that may be less vulnerable to the rapid evolution of these viruses.

Originally published at Phys.org